Approval · Notice of Compliance 21240 · 2018
VEMLIDY: Notice of Compliance 21240
Issued August 24, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21240
- Date
- August 24, 2018
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of long-term safety and efficacy data and other safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VEMLIDY | Not yet assigned | — |
Medicinal ingredients
- TENOFOVIR ALAFENAMIDE HEMIFUMARATE 25 MG per TAB